CytomX Therapeutics (CTMX) EPS (Basic) (2014 - 2026)
CytomX Therapeutics' (CTMX) quarterly EPS (Basic) came in at -$0.1 in Q1 2026, down 138.12% YoY from $0.27 in Q1 2025, and up 37.38% on a QoQ basis from -$0.16 in Q4 2025.
CytomX Therapeutics (CTMX) EPS (Basic) (2014 - 2026) Analysis & Trends
CytomX Therapeutics (CTMX) has 13 years of EPS (Basic) data on file, last reported at -$0.1 in Q1 2026.
- Quarterly EPS (Basic) fell 138.12% year-over-year to -$0.1 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$0.31 (down 165.33% YoY) and the FY2025 annual result came in at -$0.15, down 139.13% from the prior year.
- EPS (Basic) improved to -$0.1 in Q1 2026, from -$0.16 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $0.27 in Q1 2025 to a low of -$0.49 in Q1 2022.
- A 5-year average of -$0.07 and a median of -$0.05 in 2023 frame the typical range for EPS (Basic).
- The widest YoY moves for EPS (Basic): up 1871.26% in 2024, down 371.19% in 2024.
- Tracing CTMX's EPS (Basic) over 5 years: stood at -$0.13 in 2022, then soared by 108.5% to $0.01 in 2023, then jumped by 1871.26% to $0.22 in 2024, then tumbled by 173.53% to -$0.16 in 2025, then jumped by 37.38% to -$0.1 in 2026.
- The last three EPS (Basic) figures came in at -$0.1 (Q1 2026), -$0.16 (Q4 2025), and -$0.09 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 7.59 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.06 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.16 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.18 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.23 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.06 |
| 10 | CytomX Therapeutics | 732.14 Mn | 401.86 Mn | - | -0.09 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.09 |
| Mar 31, 2026 | -0.10 |
| Dec 31, 2025 | -0.16 |
| Sep 30, 2025 | -0.09 |
| Jun 30, 2025 | 0.00 |
| Mar 31, 2025 | 0.27 |
| Dec 31, 2024 | 0.22 |
| Sep 30, 2024 | 0.07 |
| Jun 30, 2024 | -0.08 |
| Mar 31, 2024 | 0.17 |
| Dec 31, 2023 | 0.01 |
| Sep 30, 2023 | 0.04 |
| Jun 30, 2023 | -0.02 |
| Mar 31, 2023 | -0.05 |
| Dec 31, 2022 | -0.13 |
| Sep 30, 2022 | -0.44 |
| Jun 30, 2022 | -0.45 |
| Mar 31, 2022 | -0.49 |
| Dec 31, 2021 | -0.54 |
| Sep 30, 2021 | -0.48 |